Literature DB >> 8519612

Clinical features of systemic lupus erythematosus.

M Petri1.   

Abstract

Major findings in the understanding of the epidemiology of systemic lupus erythematosus and in the description and understanding of its presentation and course in individual organ systems are reviewed. The role of serologic tests as correlates of disease activity remains controversial. No consensus has been reached on the association of either corticosteroid dose or of antiphospholipid antibodies with avascular necrosis of bone. Multiple rare presentations of cutaneous lupus have been reviewed during the past year. The role of hormones in the activity of lupus and the use of hormonal agents in the treatment of lupus are rapidly expanding and contentious areas of research. Cognitive function deficit continues to be an area of great interest, with studies differing on whether psychiatric disorders or organic lupus (or both) are responsible. Finally, fatigue and the potential role of fibromyalgia as an explanation for "lupus fatigue," are of major interest.

Entities:  

Mesh:

Year:  1995        PMID: 8519612     DOI: 10.1097/00002281-199509000-00006

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  11 in total

1.  Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus.

Authors:  Mansoor Karimifar; Afshin Tahmasebi; Zahra Sayed Bonakdar; Samaneh Purajam
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

2.  Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus.

Authors:  Loes van den Berg; Hans Nossent; Ole Rekvig
Journal:  Clin Rheumatol       Date:  2005-11-23       Impact factor: 2.980

3.  Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.

Authors:  G S Alarcón; J Calvo-Alén; G McGwin; A G Uribe; S M A Toloza; J M Roseman; M Fernández; B J Fessler; L M Vilá; C Ahn; F K Tan; J D Reveille
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

4.  Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII.

Authors:  Paula I Burgos; Graciela S Alarcón; Gerald McGwin; Kendra Q Crews; John D Reveille; Luis M Vilá
Journal:  Arthritis Rheum       Date:  2009-09-15

5.  Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up.

Authors:  Ina Kötter; Daniela Neuscheler; Ilhan Günaydin; Dorothee Wernet; Reinhild Klein
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

6.  SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature.

Authors:  Amy M Becker; Kathryn H Dao; Bobby Kwanghoon Han; Roger Kornu; Shuchi Lakhanpal; Angela B Mobley; Quan-Zhen Li; Yun Lian; Tianfu Wu; Andreas M Reimold; Nancy J Olsen; David R Karp; Fatema Z Chowdhury; J David Farrar; Anne B Satterthwaite; Chandra Mohan; Peter E Lipsky; Edward K Wakeland; Laurie S Davis
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

7.  Health service utilization among African American women living with systemic lupus erythematosus: perceived impacts of a self-management intervention.

Authors:  Abena A Twumasi; Anna Shao; Charmayne Dunlop-Thomas; Cristina Drenkard; Hannah L F Cooper
Journal:  Arthritis Res Ther       Date:  2019-06-25       Impact factor: 5.156

8.  An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus.

Authors:  C Pena-Rossi; E Nasonov; M Stanislav; V Yakusevich; O Ershova; N Lomareva; H Saunders; J Hill; I Nestorov
Journal:  Lupus       Date:  2009-05       Impact factor: 2.911

Review 9.  Systemic Lupus Erythematosus: An Overview of the Disease Pathology and Its Management.

Authors:  Asad Ali; Zohaib Sayyed; Muhammad Atif Ameer; Abdul Wahab Arif; Fnu Kiran; Ayesha Iftikhar; Waleed Iftikhar; Malik Qistas Ahmad; Muhammad Bilal Malik; Vijay Kumar; Arjan Dass; Shahzad Ahmed Sami; Fnu Sapna; Neha Waqas
Journal:  Cureus       Date:  2018-09-11

10.  Overcoming barriers to recruitment and retention of African-American women with SLE in behavioural interventions: lessons learnt from the WELL study.

Authors:  Cristina Drenkard; Kirk Easley; Gaobin Bao; Charmayne Dunlop-Thomas; S Sam Lim; Teresa Brady
Journal:  Lupus Sci Med       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.